Syntax designs adaptive trials for subpopulations with potential benefits.
problem Identifying subpopulations with positive treatment effects in diverse patient populations.
method Adaptive patient recruitment and synthetic control estimation.
result Syntax outperforms conventional trial designs in identifying beneficial subpopulations.
Framework for estimating treatment effects using external control data.
problem Improving efficiency in estimating average treatment effects (ATE) in hybrid trials.
method Developed a formal causal inference framework based on exchangeability assumptions and graphical criteria. Proposed estimators and efficient doubly-robust methods.
result Established finite-sample performance and demonstrated application to spinal muscular atrophy trial.
Digital twins improve single-arm trials by providing robust treatment effect estimates.
problem Lack of control arms in single-arm trials limits their gold-standard evidence.
method Outcome-model-based synthetic controls using machine learning models trained on historical data.
result Digital twins offer more robust treatment effect estimates and principled corrections.
Generative AI models improve clinical trial data by generating survival outcomes.
problem Generating valid survival outcomes for clinical trials with synthetic data.
method A variational autoencoder (VAE) that jointly generates mixed-type covariates and survival outcomes.
result The method outperforms GAN baselines on fidelity, utility, and privacy metrics.
Machine learning boosts RCT efficiency by controlling type I error and improving statistical power.
problem Improving statistical efficiency in RCTs with complex covariate adjustments.
method Machine learning-assisted adjustment under Rosenbaum's framework for exact tests.
result The proposed method robustly controls type I error and significantly boosts statistical efficiency.
New TTP framework fuses control arms while controlling Type-I error.
problem Bias in borrowing control data from previous trials.
method Kernel two-sample testing via MMD and equivalence testing.
result Higher power than standard TTP methods while maintaining error control.
The paper compares methods for estimating heterogeneous treatment effects using multiple randomized trials.
problem Estimating heterogeneous treatment effects reliably and precisely with a single dataset is challenging.
method Non-parametric approaches for estimating heterogeneous treatment effects using data from multiple trials.
result Methods that directly allow for heterogeneity of the treatment effect across trials perform better than those that do not.
New estimator improves policy evaluation in resource allocation RCTs.
problem Difficulty in evaluating policies optimizing limited resource allocation through RCTs.
method Proposes a novel estimator involving retrospective reshuffling of participants across experimental arms.
result The new estimator provides more accurate policy evaluations than common methods.
New methods improve subgroup analysis in trials with limited data.
problem Limited sample sizes in subgroup analyses of randomized controlled trials.
method Two TMLEs that borrow information from non-subgroup participants.
result Improved precision in subgroup-specific treatment effect estimates.
WHOMP optimizes randomized controlled trials by minimizing subgroup bias.
problem Minimizing subgroup bias in randomized controlled trials.
method Wasserstein Homogeneity Partition (WHOMP) method.
result WHOMP optimally minimizes type I and type II errors in trials.
The P300 event-related potential (ERP), evoked in scalp-recorded electroencephalography (EEG) by external stimuli, has proven to be a reliable response for controlling a BCI. The P300 component of an event related potential is thus widely used in brain-computer interfaces to translate the subjects' intent by mere thoug…
A novel dose-finding design for cancer clinical trials using level set estimation.
problem Finding the maximum tolerated dose (MTD) in phase I cancer clinical trials.
method Proposes a novel dose-finding design based on level set estimation (LSE) to determine the next dose.
result The proposed LSE design achieves higher accuracy in estimating the MTD and lower risk of overdosing compared to existing designs.
Causal ML methods failed to validate their personalized treatment effects in two large trials.
problem Validating causal machine learning methods for personalized treatment effects in precision medicine.
method Assessed 17 mainstream causal heterogeneity ML methods using two large randomized controlled trials.
result None of the ML methods reliably validated their performance, internal or external, showing significant discrepancies between training and test data.
Randomized Controlled Trials (RCTs) are the gold standard for comparing the effectiveness of a new treatment to the current one (the control). Most RCTs allocate the patients to the treatment group and the control group by uniform randomization. We show that this procedure can be highly sub-optimal (in terms of learnin…
A-TMLE estimates ATE from RCT and RWD, achieving super-efficiency.
problem Estimating ATE from RCT and RWD data.
method Adaptive-TMLE framework for decomposing and estimating ATE.
result A-TMLE is root-n consistent and asymptotically normal, achieving super-efficiency.
The paper evaluates index-based allocation policies using data from randomized control trials.
problem Evaluating index-based allocation policies in resource-scarce scenarios.
method Using data from randomized control trials, the paper introduces an efficient estimator and methods for computing asymptotically correct confidence intervals.
result Valid statistical conclusions can be drawn for index-based allocation policies.
MEC-Cox: A Machine-Learning-Assisted Generalized Entropy Calibration Method for Estimating ATT Marginal Hazard-Ratio
problem Estimating ATT marginal hazard-ratio in externally controlled survival trials
method Machine-learning-assisted generalized entropy calibration for IPW Cox regression
result Reduces bias, increases efficiency, and improves coverage
This study evaluates subgroup analysis methods for time-to-event outcomes in randomized controlled trials.
problem Identifying subgroups of good responders in non-significant randomized controlled trials.
method Evaluation of several subgroup analysis algorithms for time-to-event outcomes using synthetic and semi-synthetic data.
result Provides a new synthetic and semi-synthetic data generation process and an open-source Python package for benchmarking.
This paper describes Simpson's paradox, and explains its serious implications for randomised control trials. In particular, we show that for any number of variables we can simulate the result of a controlled trial which uniformly points to one conclusion (such as 'drug is effective') for every possible combination of t…
Adaptive Prespecification improves precision in randomized trials.
problem Selecting optimal covariates for precision in randomized trials.
method Adaptive Prespecification using V-fold cross-validation and influence curve-squared loss function.
result Substantial gains in precision, equivalent to 20-43% reductions in sample size for the same power.
New method detects biomarker-treatment interactions in clinical trials.
problem Detecting interactions between high-dimensional biomarkers and treatments in randomized trials.
method Two-stage penalized regression screening using ridge regression for multivariate screening.
result Ridge regression screening provides greater power than traditional methods in correlated data.
Participants enrolled into randomized controlled trials (RCTs) often do not reflect real-world populations. Previous research in how best to translate RCT results to target populations has focused on weighting RCT data to look like the target data. Simulation work, however, has suggested that an outcome model approach …
New method uses latent variables to estimate treatment effects from single-arm trials.
problem Estimating treatment effects from single-arm trials due to lack of external control groups.
method Latent-variable modeling with amortized variational inference for patient matching and direct effect estimation.
result Improved performance in direct treatment effect estimation and effect estimation via patient matching compared to previous methods.
Machine learning improves learning and memory retention by optimizing study sessions.
problem Improving learning and memory retention methods for factual material.
method Large-scale randomized controlled trial with machine learning optimization of study sessions.
result Study sessions optimized with machine learning lead to 67% longer retention and 50% higher return rate.
Bayesian method improves clinical trial efficiency.
problem Increase treatment effect estimates in clinical trials.
method Combines prognostic covariate adjustment with a Bayesian framework.
result Substantial increase in statistical power with controlled type I error.
New methods improve causal inference generalization using trial and observational data.
problem Limited trial data makes generalizing causal inferences to target populations statistically infeasible.
method Develops algorithms that combine trial and observational data to estimate complex nuisance functions.
result Improves generalization of causal inferences when the additional observational study is high-quality.
Optimizes costs in uncertain Markov systems using risk filters.
problem Optimizing costs in systems with model uncertainty and unknown parameters.
method Risk filters and Bellman principle of optimality applied to Bayesian framework.
result Derives the Bellman principle for non-standard risk-averse control problems.
This paper addresses the question of how a previously available control policy πs can be used as a supervisor to more quickly and safely train a new learned control policy πL for a robot. A weighted average of the supervisor and learned policies is used during trials, with a heavier weight initially on the superv…
New framework for adaptive clinical trials to address real-world challenges.
problem Real-world challenges in post-regulatory clinical trials.
method RFAN framework integrating regulatory constraints and treatment policy value.
result Empirical evaluation of RFAN's performance.
New disease drug trials use ML to predict best therapy.
problem Developing new drugs faster than usual clinical trials.
method Use Neural Network to predict drug effects from patient data.
result Neural Network outperforms traditional placebo-controlled trials.
Develops a TL framework for estimating RMST difference in clinical trials.
problem Estimating RMST difference in clinical trials with time-to-event outcomes.
method Targeted learning (TL) framework using pseudo-observations and copy reference (CR) approach for sensitivity analysis.
result Demonstrated the effectiveness of the TL framework using real data.
G-computation improves clinical trial power with machine learning.
problem Balancing prognostic factors in randomized trials to prevent near-confounders.
method G-computation with penalized models (Lasso, Elasticnet) and algorithm-based methods (neural network, SVM, super learner).
result G-computation with Elasticnet and splines reduces variance and increases power in RCTs.
Shared Keyboard design improves phase I clinical trials by borrowing information across doses.
problem Interim decisions based on current dose data may overlook signals from neighboring doses.
method Bayesian model-assisted design using Beta kernel process with kernel-weighted pseudo-counts.
result Significant improvements in identifying maximum tolerated dose and safety.
Two-stage TMLE reduces bias and improves efficiency in CRTs.
problem Differential outcome measurement and imbalance in baseline predictors in CRTs.
method Two-stage targeted minimum loss-based estimator (TMLE) to adjust for baseline covariates.
result Our approach nearly eliminates bias due to differential outcome measurement.
Unified Bayesian framework improves clinical trial hypothesis testing.
problem Lack of transparency and inability to quantify evidence in traditional P-values.
method Interval null hypothesis framework combined with Bayes factor-based tests.
result Bayesian interval hypothesis testing ensures frequentist error control and interpretability.
Study designs statistical inference for collaborative science teams.
problem Maintaining scientific rigor in distributed, collaborative research.
method Analyzes hypothesis testing with strategic agents and principals.
result Principal can design policies to control posterior probability of null.
New method uses observational data to improve trial design efficiency.
problem Scarce randomized controlled trials; inefficiency of using observational data.
method Active Residual Learning, R-Design framework, R-EPIG criterion.
result Efficiently estimating residuals to correct observational bias improves trial design.
DARTS optimizes covariate selection in trials with limited data.
problem Limited budget for high-dimensional pretreatment data.
method Dynamic Adaptive Rerandomization via Thompson Sampling (DARTS).
result DARTS efficiently concentrates budget on informative features.
New approach estimates treatment effects from decentralized data.
problem Estimating treatment effects from multiple studies with limited data.
method Three classes of ATE estimators derived from Plug-in G-Formula.
result Asymptotic variance of estimators for linear models derived.
Privacy-preserving inference for clinical trials using differential privacy.
problem Balancing knowledge sharing and privacy in healthcare data.
method Differential privacy (DP) applied to log-linear belief updates in distributed settings.
result Differentially private, distributed inference methods outperform existing techniques.
Study on the probability of immunity and its bounds.
problem Estimating the probability of immunity and its bounds.
method Derive necessary and sufficient conditions for non-immunity and ε-bounded immunity; introduce indirect immunity; propose sensitivity analysis.
result Estimate the probability of benefit and produce tighter bounds of the probability of benefit.
Improves trial efficiency by adjusting for historical prognostic scores.
problem Reducing statistical uncertainty in randomized trial estimates.
method Linear covariate adjustment using a prognostic model trained on historical data.
result Prognostic covariate adjustment achieves minimum variance and reduces mean-squared error.
A new framework for adaptive behavior using reusable value profiles.
problem Adaptive behavior in changing environments requires switching among value-control regimes, but maintaining separate parameters for each situation is impractical.
method Introduces value profiles: reusable bundles of parameters assigned to hidden states, allowing for state-conditional strategy recruitment without independent parameters for each context.
result Profile-based models outperform simpler alternatives in probabilistic reversal learning, suggesting belief-dependent control of adaptive behavior.
Proposes dynamic borrowing method for historical data in clinical trials.
problem Insufficient statistical power in rare and pediatric disease clinical trials.
method Dynamic borrowing method based on frequentist approach using similarity measures.
result Demonstrates usefulness of dynamic borrowing in reanalyzing clinical trial data.
A new method improves treatment effect inferences in RCTs by adjusting for covariates and heteroskedasticity.
problem Improving treatment effect inferences in RCTs with efficient and powerful methods.
method Weighted Prognostic Covariate Adjustment Method (Weighted PROCOVA) for heteroskedasticity.
result The method reduces variance, maintains Type I error rate, and increases test power for treatment effect.
Optimizes subgroup selection in clinical trials.
problem Identifying regions in feature space where a regression function exceeds a threshold.
method Formulates subgroup selection as constrained optimisation, determining minimax optimal rate for regret.
result Determines the minimax optimal rate for regret in sample size and Type I error probability.
Framework tests CATE homogeneity across trials and evaluates confounding.
problem Assessing treatment effect consistency across randomized and observational studies.
method Leverages multiple randomized trials to test CATE homogeneity and compares with observational data.
result Identifies potential confounding and effect heterogeneity in treatment effects.
Adaptive experiment designs can dramatically improve statistical efficiency in randomized trials, but they also complicate statistical inference. For example, it is now well known that the sample mean is biased in adaptive trials. Inferential challenges are exacerbated when our parameter of interest differs from the pa…